1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Home and Community Care Block Grant (HCCBG) for Older Adults is sponsored by North Carolina Division of Aging and Adult Services (DAAS). The HCCBG provides a common funding stream for a comprehensive and coordinated system of home and community-based services and opportunities for older adults (60 years and older) and their unpaid primary caregivers.
Services can include adult day care, care management, congregate nutrition, home-delivered meals, in-home aid, and transportation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Local agencies within the community that provide services to people ages 60 and older that are socially and economically needy. Administered through Area Agencies on Aging. Confirm the full requirements in the official notice before applying.
Home and Community Care Block Grant (HCCBG) for Older Adults is funded by North Carolina Division of Aging and Adult Services (DAAS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article